The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.
Mengod G, Charli JL, Palacios JM
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to examine the effect of PMI (5.5-15 h), patient age (42-82 y), gender and Huntington's or Parkinson's disease on the levels of neuropeptide transcripts by ISH and northern blot. Specimens from 12 control and 6 Huntington's disease patients were used for analysis.
Summary of Findings
No significant effects of patient age, gender or PMI on the optical density of the ISH signal from preproenkephalin A, somatostatin or neuropeptide Y was observed in the three regions of striatum. Striatum allowed for observation of preproenkephalin A, somatostatin, neuropeptide Y, but not cholecystokinin, arginine-vasopressin and oxytocin. In the hypothalamus, preproenkephalin A, somatostatin, oxytocin and arginine- vasopressin were observed. Huntington's and Parkinson's disease resulted in decreased preproenkephalin A, but not somatostatin or neuropeptide Y. The authors conclude that neuropeptide transcript levels may be examined by ISH or northern blot in postmortem tissue even after a PMI of 15 h and while brain region and disease specific differences occur there was no effect of gender or age.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
Cardiovascular DiseaseHuntington's DiseaseParkinson's DiseaseAutopsyPlatforms
RNAIn situ hybridizationRNANorthern blotPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Huntington's diseaseNo neuropsychiatric disorderParkinson's diseasePreaquisition Patient age 42 y62 y77 y82 yPreaquisition Patient gender FemaleMalePreaquisition Postmortem interval 14.5 h15 h5.5 h6.5 h8.5 hBiospecimen Acquisition Biospecimen location HypothalamusStriatum-accumbensStriatum-caudateStriatum-putamenIn situ hybridization Specific Targeted nucleic acid Neuropeptide YPreproenkephalin ASomatostatin